Leukemia
Study results from E. Estey et al provide new insights into leukemia
Published in Blood Weekly, December 10th, 2009
"Specifically, randomized phase III designs focus on improvements that are more significant statistically than medically and put an emphasis on avoiding a false positive result that is more appropriate for diseases that are curable, in contrast to acute leukemias The resultant large sample sizes needed for each treatment restrict the trial to one or two new treatments.. although historical reality Suggests the difficulty in knowing, without...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-12-10)
More Articles from Blood Weekly
- American College of Radiology / American Roentgen Ray Society
Radiology procedure may help increase long-term survival in patients with severe liver cancer - University of Maryland Medical Center
Tobacco smoke exposure before heart transplantation may increase the risk of transplant failure - Wiley-Blackwell
Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US - Wiley-Blackwell
Drug side effects a key factor in reduced quality of life for kidney transplant patients - Wiley-Blackwell
New data emerges on liver transplant survival rates - Ambit Biosciences Corporation
Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
